As per email received from National Stock Exchange of India Limited dated May 27, 2025, enclosed Financial Results in a machine-readable and searchable form.
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.5 pts more than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The company is submitting its financial results to the National Stock Exchange in a machine-readable and searchable (XBRL) format, as requested via NSE's email dated May 27, 2025. This is a procedural, routine compliance filing and does not itself disclose fresh financial numbers. The underlying financial results are being resubmitted in a format mandated by the exchange for easier data processing. No specific revenue, profit, or margin figures are revealed in this announcement.
No direct impact on shareholders or stock price — this is a standard regulatory filing about the format of result submission rather than new financial information or corporate action.